Skip to main content

Adagio Medical Holdings, Inc.

For the period ended Dec 31, 2024. Filed Mar 27, 2025.

View on SEC.gov

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2024 · Filed Mar 27, 2025

ADGM$1.92Day change unavailableStored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits
Contents

Table of Contents

TABLE OF CONTENTS
​Page
Statement Regarding Forward Looking Statements4
​​
PART I
​​
Item 1. Business9
Item 1A. Risk Factors27
Item 1B. Unresolved Staff Comments83
Item 1C. Cybersecurity83
Item 2. Properties83
Item 3. Legal Proceedings83
Item 4. Mine Safety Disclosures84
​​
PART II
​​
Item 5. Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities84
Item 6. Reserved84
Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations85
Item 7A. Quantitative and Qualitative Disclosures About Market Risk107
Item 8. Financial Statements and Supplementary Data108
Item 9. Changes in and Disagreements with Accountants on Accounting and Financial Disclosure164
Item 9A. Controls and Procedures164
Item 9B. Other Information165
Item 9C. Disclosure Regarding Foreign Jurisdictions that Prevent Inspections165
​​
PART III
​​
Item 10. Directors, Executive Officers and Corporate Governance165
Item 11. Executive Compensation166
Item 12. Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters166
Item 13. Certain Relationships and Related Transactions, and Director Independence166
Item 14. Principal Accounting Fees and Services166
​​
PART IV
​​
Item 15. Exhibits and Financial Statement Schedules167
​​
Signatures169
​​
​​
​​

Unless the context indicates otherwise, references in this Annual Report to the “Company,” “Adagio,” “Successor,” “we,” “us,” “our” and similar terms refer to Adagio Medical Holdings, Inc. (f/k/a Aja Holdco, Inc.) and its consolidated subsidiaries. References to “ListCo” refer to Aja Holdco, Inc. prior to the consummation of the Business Combination (as defined below).

On July 31, 2024, or the Closing Date (as defined below), ARYA Sciences Acquisition Corp IV, a Cayman Islands exempted company (“ARYA”), Aja Holdco, Inc. (“ListCo”), a Delaware corporation and wholly-owned subsidiary of ARYA, Aja Merger Sub 1, a Cayman Islands exempted company and wholly-owned subsidiary of ListCo (“ARYA Merger Sub”), Aja Merger Sub 2, Inc., a Delaware corporation and wholly-owned subsidiary of ListCo (“Company Merger Sub”), and Adagio Medical, Inc., a Delaware corporation (“Legacy Adagio” or the “Predecessor”), consummated the business combination (the “Business Combination”) pursuant to the terms of the Business Combination Agreement, dated February 13, 2024, by and among the foregoing parties, as amended by the Consent and Amendment No. 1 to Business Combination Agreement, dated as of June 25, 2024, by and between ARYA and Legacy Adagio (the “Business Combination Agreement”).

Pursuant to the Business Combination Agreement, on the Closing Date, (i) ARYA Merger Sub merged with and into ARYA (the “ARYA Merger”) and Company Merger Sub merged with and into Legacy Adagio (the “Adagio Merger” and, together with the ARYA Merger, the “Mergers”), with ARYA and Legacy Adagio surviving the Mergers and, after giving effect to such Mergers, each of ARYA and Legacy Adagio becoming a wholly-owned subsidiary of ListCo (the time that the ARYA Merger becomes effective being referred to as the “ARYA Merger Effective Time,” the time that the Adagio Merger becomes effective being referred to as the “Adagio Merger Effective Time,” the time after which both Mergers become effective being referred to as the “Closing,” and the date on which the Closing occurs being referred to as the “Closing Date”), (ii) ListCo filed with the Secretary of State of the State of Delaware an amended and restated certificate of incorporation of ListCo (the “Charter”), and the board of directors of ListCo approved and adopt amended and restated bylaws of ListCo (the “Bylaws”), and (iii) ListCo changed its name to Adagio Medical Holdings, Inc.

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.